Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Eur J Pharmacol ; 683(1-3): 54-62, 2012 May 15.
Article in English | MEDLINE | ID: mdl-22465181

ABSTRACT

Natural phenol licorice compounds have been shown to induce apoptosis in cancer cells. 3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl indazole (YC-1) may enhance the sensitivity of cancer cells to anticancer drugs. However, the combined effect of licochalcone A and YC-1 on cell death in ovarian cancer cells has not been studied. We assessed the combined effect of licochalcone A and YC-1 on apoptosis in human epithelial ovarian carcinoma cell lines in relation to the cell death process. In the OVCAR-3 and SK-OV-3 cell lines, licochalocone A induced a decrease in Bid, Bcl-2, Bcl-xL and survivin protein levels; an increase in Bax levels; loss of the mitochondrial transmembrane potential; cytochrome c release; activation of caspases (-8, -9 and -3); cleavage of PARP-1; and an increase in the tumor suppressor p53 levels. YC-1 enhanced licochalcone A-induced apoptosis-related protein activation, nuclear damage and cell death. These results suggest that YC-1 may potentiate the apoptotic effect of licochalcone A on ovarian carcinoma cell lines by increasing the activation of the caspase-8- and Bid-dependent pathway and the mitochondria-mediated apoptotic pathway, leading to caspase activation. The combination of licochalcone A and YC-1 may confer a benefit in the treatment of human epithelial ovarian adenocarcinoma.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Chalcones/pharmacology , Enzyme Activation/drug effects , Guanylate Cyclase/chemistry , Indazoles/pharmacology , Neoplasms, Glandular and Epithelial/drug therapy , Ovarian Neoplasms/drug therapy , Apoptosis Regulatory Proteins/metabolism , Carcinoma/drug therapy , Carcinoma/metabolism , Carcinoma/pathology , Carcinoma, Ovarian Epithelial , Caspases/chemistry , Caspases/metabolism , Cell Line, Tumor , Cell Nucleus/drug effects , Drug Interactions , Female , Humans , Neoplasm Proteins/agonists , Neoplasms, Glandular and Epithelial/metabolism , Neoplasms, Glandular and Epithelial/pathology , Ovarian Neoplasms/metabolism , Ovarian Neoplasms/pathology , Poly (ADP-Ribose) Polymerase-1 , Poly(ADP-ribose) Polymerases/metabolism , Proteolysis/drug effects , Signal Transduction/drug effects , Tumor Suppressor Protein p53/metabolism
2.
Brain Res ; 1036(1-2): 18-26, 2005 Mar 02.
Article in English | MEDLINE | ID: mdl-15725397

ABSTRACT

The effect of 3-morpholinosydnonimine (SIN-1) against the cytotoxicity of MG132, a proteasome inhibitor, in differentiated PC12 cells was assessed by measuring the effect on the mitochondrial membrane permeability. Treatment of PC12 cells with MG132 resulted in the nuclear damage, decrease in the mitochondrial transmembrane potential, cytosolic accumulation of cytochrome c, activation of caspase-3, increase in the formation of reactive oxygen species (ROS), and depletion of GSH. Addition of SIN-1, a producer of nitric oxide (NO) and superoxide, differentially reduced the MG132-induced cell death and GSH depletion concentration dependently with a maximal inhibitory effect at 150 microM. Carboxy-PTIO, superoxide dismutase, Mn-TBAP, and ascorbate prevented the inhibitory effect of SIN-1 on the cytotoxicity of MG132. SIN-1 inhibited the MG132-induced change in the mitochondrial membrane permeability, ROS formation and decrease in GSH contents in PC12 cells. S-nitroso-N-acetyl-DL-penicillamine reduced the MG132-induced cell death in PC12 cells, whereas peroxynitrite and H2O2 did not affect the cytotoxicity of MG132. The results suggest that NO and superoxide liberated from SIN-1 exert an inhibitory effect against the cytotoxicity of MG132. SIN-1 may inhibit the MG132-induced viability loss in PC12 cells by suppressing change in the mitochondrial membrane permeability that is associated with oxidative damage.


Subject(s)
Energy Metabolism/physiology , Leupeptins/antagonists & inhibitors , Mitochondria/metabolism , Molsidomine/analogs & derivatives , Molsidomine/pharmacology , Nitric Oxide/antagonists & inhibitors , Oxidative Stress/physiology , Animals , Antioxidants/pharmacology , Cell Death/drug effects , Cell Death/physiology , Cell Membrane Permeability/drug effects , Cell Membrane Permeability/physiology , Cysteine Proteinase Inhibitors/toxicity , Cytochromes c/metabolism , Dose-Response Relationship, Drug , Energy Metabolism/drug effects , Enzyme Inhibitors/pharmacology , Free Radicals/metabolism , Glutathione/metabolism , Leupeptins/toxicity , Mitochondria/drug effects , Nitric Oxide/metabolism , Nitric Oxide Donors/pharmacology , Oxidative Stress/drug effects , PC12 Cells , Proteasome Endopeptidase Complex/metabolism , Proteasome Inhibitors , Rats , Superoxides/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL